Dataset Information


The design, synthesis and biological evaluation of conformationally restricted 4-substituted-2,6-dimethylfuro[2,3-d]pyrimidines as multi-targeted receptor tyrosine kinase and microtubule inhibitors as potential antitumor agents.

ABSTRACT: A series of eleven conformationally restricted, 4-substituted 2,6-dimethylfuro[2,3-d]pyrimidines was designed to explore the bioactive conformation required for dual inhibition of microtubule assembly and receptor tyrosine kinases (RTKs), and their biological activities are reported. All three rotatable single bonds in the lead compound 1 were sequentially restricted to address the role of each in SAR for microtubule and RTK inhibitory effects. Compounds 2, 3, 7 and 10 showed microtubule depolymerizing activity comparable to or better than the lead 1, some with nanomolar EC50 values. While compound 8 had no effect on microtubules, 8 and 10 both showed potent RTK inhibition with nanomolar IC50s. These compounds confirm that the bioactive conformation for RTK inhibition is different from that for tubulin inhibition. The tetrahydroquinoline analog 10 showed the most potent dual tubulin and RTK inhibitory activities (low nanomolar inhibition of EGFR, VEGFR2 and PDGFR-?). Compound 10 has highly potent activity against many NCI cancer cell lines, including several chemo-resistant cell lines, and could serve as a lead for further preclinical studies.


PROVIDER: S-EPMC4410085 | BioStudies | 2015-01-01

REPOSITORIES: biostudies

Similar Datasets

2013-01-01 | S-EPMC3850778 | BioStudies
2009-01-01 | S-EPMC2742177 | BioStudies
2017-01-01 | S-EPMC5362409 | BioStudies
1000-01-01 | S-EPMC4100990 | BioStudies
2013-01-01 | S-EPMC3674157 | BioStudies
2013-01-01 | S-EPMC3572549 | BioStudies
2008-01-01 | S-EPMC3125133 | BioStudies
2015-01-01 | S-EPMC4821443 | BioStudies
2017-01-01 | S-EPMC5430391 | BioStudies
2011-01-01 | S-EPMC3184787 | BioStudies